Directory of global suppliers across science, technology, industrial, medical and dental uses

www.utilisegold.com

Hello, you either have JavaScript turned off or an old version of Adobe's Flash Player. Get the latest Flash player.

Gold

Gold included in cancer-detecting 'chemical nose' > Gold News > Utilise Gold. Scientific, industrial and medical applications, products ,suppliers from the World Gold Council

 
 
 

Gold included in cancer-detecting 'chemical nose'

The news feeds on this site are independently provided by Adfero Limited © and do not represent the views or opinions of the World Gold Council.

Tuesday, 23rd June 2009 (5205 views)

Gold has been used by researchers at the University of Massachusetts Amherst to develop a 'chemical nose' that could be used to seek out cancer cells.

A team of scientists led by Vincent Rotello and Joseph Jerry have employed the precious metal in the production of the cancer detection device, which is constructed using an array of nanoparticles and polymers.

As well as establishing the differences between healthy and cancerous cells, the researchers are also able to identify metastatic and non-metastatic cancer cells.

"The chemical nose can be designed to alert doctors of the most invasive cancer types, those for which early treatment is crucial," Mr Rotello explained.

He said that the team intends to work on developing the nose to give more precise feedback to doctors, adding that a wider variety of nanoparticles will be added in order to improve the results that are gathered.

The precious metal is often used in the development of cancer treatment techniques, with Massachusetts Institute of Technology researchers recently suggesting gold nanorods could help destroy malignant cells.

 

« Back to Gold News stories

 

Gold News Archive:

 
 
News provided by Adfero Ltd

Search

Search Utilise Gold.

  • Gold Spot Price
  • Bid: $1249.80
  • Ask: $1250.60
  • Last Update: 02:42 BST
  • 3 Sep 2010
© 2010 World Gold Council - all rights reserved. Produced and managed by CFP Group.